Commentary

Redesign needed for Alzheimer’s screening programs

Publish date: September 16, 2013

 

Dr. Caselli is a professor of neurology and associate director and clinical core director of the Alzheimer’s Disease Center at the Mayo Clinic in Scottsdale, Ariz. He has no relevant financial disclosures.

Pages

Recommended Reading

Aerobic exercise boosts brain power in mild cognitive impairment
MDedge Psychiatry
Higher glucose linked to increased dementia risk
MDedge Psychiatry
New drug matched donepezil’s efficacy in mild to moderate Alzheimer’s
MDedge Psychiatry
Alzheimer’s biomarkers have limited use in diagnosing frontotemporal dementia
MDedge Psychiatry
Labor induction, augmentation may be tied to autism risk
MDedge Psychiatry
Studies speak volumes about brain changes and cognition in women
MDedge Psychiatry
For atypical dementia, temporoparietal cortical thickness beats hippocampal volume
MDedge Psychiatry
Caregiver support program decreases dementia emergency visits
MDedge Psychiatry
Investigational treatments for cognitive impairment in schizophrenia
MDedge Psychiatry
Diagnosing Alzheimer’s: The eyes may have it
MDedge Psychiatry